Dexmedetomidine Protects Cortical Neurons from Propofol-Induced Apoptosis via Activation of Akt-IKK-NF-κB Signaling Pathway by α2A-adrenoceptor
- PMID: 37979083
- DOI: 10.1007/s12010-023-04768-4
Dexmedetomidine Protects Cortical Neurons from Propofol-Induced Apoptosis via Activation of Akt-IKK-NF-κB Signaling Pathway by α2A-adrenoceptor
Abstract
Context: Propofol can induce neuroapoptosis. It has been reported that dexmedetomidine (DEX) has a protective effect on propofol-induced neuroapoptosis, but the specific mechanism needs to be further explored to provide a theoretical basis for their combined use.
Objective: We aimed to explore the neuroprotective effect of DEX on primary cortical neurons treated by propofol and to elucidate the underlying mechanistic pathways.
Methods: Cortical neurons were isolated from fetal rats and treated with propofol. MTT assays were performed to detect cell viability, α-tubulin immunofluorescent assays were conducted to observe cell abnormalities, and c-caspase3 immunofluorescent assays and flow cytometry were performed to examine cell apoptosis. Further, neurons were cotreated with propofol and DEX to study DEX's neuroprotective effects on propofol-caused neuronal injuries. Finally, the α2A-adrenoceptor was knocked out and/or the Akt activator (SC-79) was added to cells co-treated with propofol and DEX. The expression levels of Akt-IKK-NF-κB pathway-related proteins were detected by western blot.
Results: Propofol decreased cell viability in a dose-dependent manner, triggered apoptosis, caused morphological abnormalities and down-regulated the phosphorylation levels of Akt, IKK, NF-κB and IκB in cortical neurons. DEX ameliorated the decrease of cell viability, alleviated neuronal apoptosis and promoted the downregulated expression levels of p-Akt, IKK, NF-κB, and IκB proteins which had been induced by propofol treatment. Western blot findings following the transfection of α2A-siRNA and the addition of SC-79 suggested that DEX's neuroprotective functions arose from the stimulation of α2A-adrenoceptors to activate the Akt-IKK-NF-κB signal pathway.
Conclusion: DEX protected neurons against propofol-induced apoptosis via activation of the Akt-IKK-NF-κB signal pathway through α2A-adrenoceptors.
Keywords: Akt-IKK-NF-κB; Apoptosis; Cortical Neuron; Dexmedetomidine; Propofol; α2A-adrenoceptor.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Istaphanous, G. K., & Loepke, A. W. (2009). General anesthetics and the developing brain. Current Opinion in Anaesthesiology, 22, 368–373. https://doi.org/10.1097/aco.0b013e3283294c9e - DOI - PubMed
-
- Miner, J. R., & Burton, J. H. (2007). Clinical practice advisory: Emergency department procedural sedation with propofol. Annals of Emergency Medicine, 50, 182–187. https://doi.org/10.1016/j.annemergmed.2006.12.017 . 187 e181. - DOI - PubMed
-
- Srivastava, V. K., Agrawal, S., Kumar, S., Mishra, A., Sharma, S., & Kumar, R. (2014). Comparison of dexmedetomidine, propofol and midazolam for short-term sedation in postoperatively mechanically ventilated neurosurgical patients. J Clin Diagn Res, 8, GC04–07. https://doi.org/10.7860/JCDR/2014/8797.4817 - DOI - PubMed - PMC
-
- Cattano, D., Young, C., Straiko, M. M., & Olney, J. W. (2008). Subanesthetic doses of propofol induce neuroapoptosis in the infant mouse brain. Anesthesia and Analgesia, 106, 1712–1714. https://doi.org/10.1213/ane.0b013e318172ba0a - DOI - PubMed
-
- Fredriksson, A., Ponten, E., Gordh, T., & Eriksson, P. (2007). Neonatal exposure to a combination of N-methyl-D-aspartate and gamma-aminobutyric acid type A receptor anesthetic agents potentiates apoptotic neurodegeneration and persistent behavioral deficits. Anesthesiology, 107, 427–436. https://doi.org/10.1097/01.anes.0000278892.62305.9c - DOI - PubMed